Cargando…

Consider Nitrofurantoin as a Cause of Lung Injury

Nitrofurantoin-induced diffuse lung toxicity is well documented in the literature but is often misdiagnosed. We describe an 82-year-old female medicated with nitrofurantoin for the previous 2 years who was admitted for dyspnoea, dry cough and fatigue for 4 months. She was febrile and tachypnoeic and...

Descripción completa

Detalles Bibliográficos
Autores principales: Almeida, Paulo, Seixas, Eduarda, Pinheiro, Beatriz, Ferreira, Pedro, Araújo, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SMC Media Srl 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886637/
https://www.ncbi.nlm.nih.gov/pubmed/31890712
http://dx.doi.org/10.12890/2019_001295
_version_ 1783474903283924992
author Almeida, Paulo
Seixas, Eduarda
Pinheiro, Beatriz
Ferreira, Pedro
Araújo, Ana
author_facet Almeida, Paulo
Seixas, Eduarda
Pinheiro, Beatriz
Ferreira, Pedro
Araújo, Ana
author_sort Almeida, Paulo
collection PubMed
description Nitrofurantoin-induced diffuse lung toxicity is well documented in the literature but is often misdiagnosed. We describe an 82-year-old female medicated with nitrofurantoin for the previous 2 years who was admitted for dyspnoea, dry cough and fatigue for 4 months. She was febrile and tachypnoeic and she presented with bilateral basal crackles, hypoxaemic respiratory failure and slightly elevated C-reactive protein levels. A chest radiograph showed bilateral air-space consolidation and interstitial infiltrates and the high-resolution computed tomography scan was evocative of a perilobular pattern of organising pneumonia (OP). Due to the clinical–radiological context, she was diagnosed with a presumable nitrofurantoin-induced OP. She was started on prednisolone 60 mg daily with a progressive improvement. It is important that clinicians are aware of the spectrum of side effects associated with nitrofurantoin so as to monitor patients. LEARNING POINTS: It is crucial to ensure that a thorough medical history with a systems review and a complete drug history are carried out. Chronic pulmonary toxicity due to nitrofurantoin is rare and it occurs primarily in older women who have been prescribed relatively small doses of nitrofurantoin for UTI prevention. The cessation of nitrofurantoin is the basis of the treatment and may be sufficient for clinical and radiological improvement.
format Online
Article
Text
id pubmed-6886637
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SMC Media Srl
record_format MEDLINE/PubMed
spelling pubmed-68866372019-12-30 Consider Nitrofurantoin as a Cause of Lung Injury Almeida, Paulo Seixas, Eduarda Pinheiro, Beatriz Ferreira, Pedro Araújo, Ana Eur J Case Rep Intern Med Articles Nitrofurantoin-induced diffuse lung toxicity is well documented in the literature but is often misdiagnosed. We describe an 82-year-old female medicated with nitrofurantoin for the previous 2 years who was admitted for dyspnoea, dry cough and fatigue for 4 months. She was febrile and tachypnoeic and she presented with bilateral basal crackles, hypoxaemic respiratory failure and slightly elevated C-reactive protein levels. A chest radiograph showed bilateral air-space consolidation and interstitial infiltrates and the high-resolution computed tomography scan was evocative of a perilobular pattern of organising pneumonia (OP). Due to the clinical–radiological context, she was diagnosed with a presumable nitrofurantoin-induced OP. She was started on prednisolone 60 mg daily with a progressive improvement. It is important that clinicians are aware of the spectrum of side effects associated with nitrofurantoin so as to monitor patients. LEARNING POINTS: It is crucial to ensure that a thorough medical history with a systems review and a complete drug history are carried out. Chronic pulmonary toxicity due to nitrofurantoin is rare and it occurs primarily in older women who have been prescribed relatively small doses of nitrofurantoin for UTI prevention. The cessation of nitrofurantoin is the basis of the treatment and may be sufficient for clinical and radiological improvement. SMC Media Srl 2019-10-30 /pmc/articles/PMC6886637/ /pubmed/31890712 http://dx.doi.org/10.12890/2019_001295 Text en © EFIM 2019 This article is licensed under a Commons Attribution Non-Commercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Articles
Almeida, Paulo
Seixas, Eduarda
Pinheiro, Beatriz
Ferreira, Pedro
Araújo, Ana
Consider Nitrofurantoin as a Cause of Lung Injury
title Consider Nitrofurantoin as a Cause of Lung Injury
title_full Consider Nitrofurantoin as a Cause of Lung Injury
title_fullStr Consider Nitrofurantoin as a Cause of Lung Injury
title_full_unstemmed Consider Nitrofurantoin as a Cause of Lung Injury
title_short Consider Nitrofurantoin as a Cause of Lung Injury
title_sort consider nitrofurantoin as a cause of lung injury
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886637/
https://www.ncbi.nlm.nih.gov/pubmed/31890712
http://dx.doi.org/10.12890/2019_001295
work_keys_str_mv AT almeidapaulo considernitrofurantoinasacauseoflunginjury
AT seixaseduarda considernitrofurantoinasacauseoflunginjury
AT pinheirobeatriz considernitrofurantoinasacauseoflunginjury
AT ferreirapedro considernitrofurantoinasacauseoflunginjury
AT araujoana considernitrofurantoinasacauseoflunginjury